Although the exact mechanism by which walking distance leads to a decrease in CHD incidence, independently of the risk factors we adjusted for, is not known, we hypothesize that walking leads to improved insulin sensitivity and better glucose control of both fasting and post load glucose. The gene discussed is INS; the disease is coronary artery disorder.